Why it was recalled
Failed Dissolution Specifications
Product description
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Lot numbers, UPCs & expiration codes
Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. .
Where it was sold
Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0357-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Jan 29, 2026
- FDA report date
- Mar 11, 2026
- Quantity
- 19,056 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Teva Pharmaceuticals USA, Inc
Original FDA data
Every field from FDA enforcement report D-0357-2026, exactly as published.
Show all FDA fields
- City
- Parsippany
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 98348
- Address
- 400 Interpace Pkwy Bldg A
- Code information
- Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. .
- Postal code
- 07054-1120
- Report date
- Mar 11, 2026
- Product type
- Drugs
- Recall number
- D-0357-2026
- Classification
- Class II
- Recalling firm
- Teva Pharmaceuticals USA, Inc
- Product quantity
- 19,056 bottles
- Reason for recall
- Failed Dissolution Specifications
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
- Distribution pattern
- Nationwide
- Recall initiation date
- Jan 29, 2026
- Initial firm notification
- Letter
- Center classification date
- Feb 27, 2026